These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12231459)

  • 1. Olfactory identification and apolipoprotein E epsilon 4 allele in mild cognitive impairment.
    Wang QS; Tian L; Huang YL; Qin S; He LQ; Zhou JN
    Brain Res; 2002 Sep; 951(1):77-81. PubMed ID: 12231459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory function in people with genetic risk of dementia.
    Salerno-Kennedy R; Cusack S; Cashman KD
    Ir J Med Sci; 2005; 174(4):46-50. PubMed ID: 16445161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease.
    Lasser RA; Dukoff R; Levy J; Levin R; Lehtimäki T; Seubert P; Sunderland T
    Int J Geriatr Psychiatry; 1998 Nov; 13(11):767-74. PubMed ID: 9850873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects.
    Smith GE; Bohac DL; Waring SC; Kokmen E; Tangalos EG; Ivnik RJ; Petersen RC
    Neurology; 1998 Feb; 50(2):355-62. PubMed ID: 9484353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Odor identification impairment in carriers of ApoE-varepsilon4 is independent of clinical dementia.
    Olofsson JK; Nordin S; Wiens S; Hedner M; Nilsson LG; Larsson M
    Neurobiol Aging; 2010 Apr; 31(4):567-77. PubMed ID: 18619712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
    Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
    Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
    Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status.
    Graves AB; Bowen JD; Rajaram L; McCormick WC; McCurry SM; Schellenberg GD; Larson EB
    Neurology; 1999 Oct; 53(7):1480-7. PubMed ID: 10534255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E status is associated with odor identification deficits in nondemented older persons.
    Murphy C; Bacon AW; Bondi MW; Salmon DP
    Ann N Y Acad Sci; 1998 Nov; 855():744-50. PubMed ID: 9929680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
    Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.
    Murphy GM; Taylor J; Kraemer HC; Yesavage J; Tinklenberg JR
    Am J Psychiatry; 1997 May; 154(5):603-8. PubMed ID: 9137113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease.
    Traykov L; Rigaud AS; Baudic S; Smagghe A; Boller F; Forette F
    J Neurol Sci; 2002 Nov; 203-204():177-81. PubMed ID: 12417380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction.
    Bacon AW; Bondi MW; Salmon DP; Murphy C
    Ann N Y Acad Sci; 1998 Nov; 855():723-31. PubMed ID: 9929677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological and genetic differences between age-associated memory impairment and mild cognitive impairment entities.
    Bartrés-Faz D; Junqué C; López-Alomar A; Valveny N; Moral P; Casamayor R; Salido A; Bel C; Clemente IC
    J Am Geriatr Soc; 2001 Jul; 49(7):985-90. PubMed ID: 11527492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smell identification test as an indicator for cognitive impairment in Alzheimer's disease.
    Suzuki Y; Yamamoto S; Umegaki H; Onishi J; Mogi N; Fujishiro H; Iguchi A
    Int J Geriatr Psychiatry; 2004 Aug; 19(8):727-33. PubMed ID: 15290695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.
    Petersen RC; Smith GE; Ivnik RJ; Tangalos EG; Schaid DJ; Thibodeau SN; Kokmen E; Waring SC; Kurland LT
    JAMA; 1995 Apr; 273(16):1274-8. PubMed ID: 7646655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease.
    Cosentino S; Scarmeas N; Helzner E; Glymour MM; Brandt J; Albert M; Blacker D; Stern Y
    Neurology; 2008 May; 70(19 Pt 2):1842-9. PubMed ID: 18401023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Patterns of cognitive impairment and apolipoprotein genotype in persons with Alzheimer's disease].
    Łuczywek E; Pffefer A; Nowicka A; Czyzewski K; ŁaŁowski M; Styczyńska M; Barcikowska M
    Neurol Neurochir Pol; 2001; 35(6):1021-33. PubMed ID: 11987699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.